医薬品受託包装市場：素材別、用途別-2025-2030年の世界予測

医薬品受託包装市場の2023年の市場規模は320億7,000万米ドルで、2024年には348億2,000万米ドルに達すると予測され、CAGR 8.91%で成長し、2030年には583億米ドルに達すると予測されています。

医薬品受託包装は、製薬会社による第三者プロバイダーへの包装サービスのアウトソーシングを指します。この業界は、製薬会社が医薬品開発やマーケティングなどのコアコンピタンスに集中できる一方で、業界標準や規制へのコンプライアンスを確保する上で、受託包装業者の専門的な知識や能力を活用できるため、不可欠な分野です。受託包装の必要性は、医薬品の製剤や包装要件の複雑化、規制当局の監視の強化、より持続可能な包装ソリューションの推進に起因しています。受託包装の用途には、ブリスター包装、ボトル充填、ラベリング、二次包装などがあり、最終用途は受託製造機関（CMO）から一般用医薬品（OTC）や医療用医薬品を製造する製薬企業まで多岐にわたる。

市場の洞察によると、主な成長要因としては、革新的なパッケージングソリューションを必要とする生物製剤や特殊医薬品の需要の高まり、製薬業界におけるアウトソーシング動向の増加、シリアル化や追跡システムのようなパッケージング技術の進歩などが挙げられます。市場関係者にとってのビジネスチャンスとしては、環境に優しいパッケージング・ソリューションを包含するサービス・ポートフォリオの拡大、パッケージング・プロセスを合理化するためのデジタル技術の採用などが挙げられます。さらに、医薬品産業が成長する新興市場への地理的拡大は有利な見通しを示しています。しかし、厳しい規制要件、コスト圧力、世界経済の不確実性による需要の変動などが課題となっています。

技術革新の展望は、患者の服薬アドヒアランスを高め、サプライチェーンの透明性を向上させ、認証を容易にするスマート包装ソリューションの開発にあります。生分解性素材やリサイクル可能な素材に関する継続的な研究は、競争優位性をもたらす可能性があります。市場の競争は激しく、急速な技術の進歩と規制の変更によってダイナミックに変化しています。持続可能な事業成長のためには、企業は最先端技術に投資し、戦略的パートナーシップや提携を促進してサービス提供を強化すべきです。さらに、コンプライアンスへの積極的なアプローチと顧客固有のニーズへの強い関心が、この進化する市場で課題を乗り切り、チャンスをつかむために不可欠となります。

市場力学：急速に進化する医薬品受託包装市場における主要市場インサイトの解明

医薬品受託包装市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬業界における便利で改ざん防止包装へのニーズの高まり
  • 世界の医薬品製造・輸出の増加
  • 医薬品包装に関する政府の厳しい基準
• 市場抑制要因
  • 高度でカスタマイズされた医薬品受託包装サービスの高コスト
• 市場機会
  • 医薬品パッケージングソリューションの技術的進歩
  • 創薬開発への多額の投資
• 市場の課題
  • 新開発の医薬品と包装材や偽造品の広告との競合

ポーターの5つの力：医薬品受託包装市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品受託包装市場における外部からの影響の把握

外部マクロ環境要因は、医薬品受託包装市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品受託包装市場における競合情勢の把握

医薬品受託包装市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医薬品受託包装市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品受託包装市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医薬品受託包装市場における成功への道筋を描く

医薬品受託包装市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品業界では、便利で改ざん防止のパッケージングに対するニーズが高まっています。
    • 世界中で医薬品の製造と輸出が増加
    • 医薬品包装に関する厳格な政府基準
  • 抑制要因
    • 高度でカスタマイズされた医薬品受託包装サービスの高コスト
  • 機会
    • 医薬品包装ソリューションにおける技術的進歩
    • 医薬品の発見と開発への多額の投資
  • 課題
    • 包装資材や広告偽造品に抵触する新開発医薬品
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 医薬品受託包装市場：素材別

• アルミホイル
• ガラス
• 紙・板紙
• プラスチックとポリマー

第7章 医薬品受託包装市場：用途別

• アンプル
• ブリスターパック
• ボトル
• バイアル

第8章 南北アメリカの医薬品受託包装市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の医薬品受託包装市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの医薬品受託包装市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Almac Group
• AmeriPac, Inc.
• Aphena Pharma Solutions Inc.
• Assemblies Unlimited Inc.
• Baxter Pharmaceutical Solutions LLC
• Catalent, Inc.
• Central Pharma Contract Packing Limited
• Daito Pharmaceutical Co., Ltd.
• Daklapack Group
• Finishing Services
• Jam Jams Group
• Jones Healthcare Group
• MJS Packaging
• Nelipak Corporation
• Nipro Corporation
• Patheon Pharma Services by Thermo Fisher Scientific Inc.
• PCI Pharma Services
• Pfizer Inc.
• Reed-Lane, Inc.
• Ropack Inc.
• Sepha Limited
• Sharp Services, LLC
• Southwest Packaging
• SternMaid GmbH
• Unicep Packaging, LLC
• Wasdell Group
• West Pharmaceutical Services, Inc.

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL CONTRACT PACKAGING MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PAPER & PAPERBOARD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. CANADA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 25. CANADA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. CHINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 37. CHINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 39. INDIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ITALY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 74. ITALY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. POLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 82. POLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. QATAR PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 84. QATAR PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 104. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

The Pharmaceutical Contract Packaging Market was valued at USD 32.07 billion in 2023, expected to reach USD 34.82 billion in 2024, and is projected to grow at a CAGR of 8.91%, to USD 58.30 billion by 2030.

Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to third-party providers. This industry segment is essential because it allows pharmaceutical companies to focus on their core competencies, such as drug development and marketing, while leveraging the specialized expertise and capabilities of contract packagers in ensuring compliance with industry standards and regulations. The necessity of contract packaging stems from the increasing complexity of drug formulations and packaging requirements, heightened regulatory scrutiny, and the push towards more sustainable packaging solutions. Applications of contract packaging include blister packaging, bottle filling, labeling, and secondary packaging, with end-use scope spanning from contract manufacturing organizations (CMOs) to pharma companies producing over-the-counter (OTC) medications and prescription drugs.

Market insights indicate that key growth factors include heightened demand for biologics and specialty drugs necessitating innovative packaging solutions, increased outsourcing trends in the pharma industry, and advancements in packaging technologies like serialization and track-and-trace systems. Opportunities for market players include expanding service portfolios to encompass eco-friendly packaging solutions and adopting digital technologies to streamline packaging processes. Moreover, geographic expansion into emerging markets with growing pharmaceutical industries presents a lucrative prospect. However, challenges include stringent regulatory requirements, cost pressures, and demand fluctuations due to global economic uncertainties.

Innovation prospects lie in developing smart packaging solutions that enhance patient adherence, improve supply chain transparency, and facilitate authentication. Continued research into biodegradable and recyclable materials can offer a competitive edge. The nature of the market is highly competitive and dynamic, driven by rapid technological advancements and regulatory changes. For sustainable business growth, companies should invest in state-of-the-art technologies and foster strategic partnerships or alliances to enhance their service offerings. Additionally, a proactive approach to compliance and a strong focus on customer-specific needs will be critical in navigating the challenges and seizing opportunities in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Contract Packaging Market

The Pharmaceutical Contract Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing need for convenient and tamper-free packaging in pharmaceutical industries
  • Rise manufacturing and export of pharmaceutical products worldwide
  • Stringent government standards for pharmaceutical packaging
• Market Restraints
  • High cost of advanced and customized pharmaceutical contract packaging services
• Market Opportunities
  • Technological advancements in pharmaceutical packaging solutions
  • Significant investments in drug discovery and development
• Market Challenges
  • Newly developed drugs conflicting with packaging material and advertising forged products

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Contract Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Contract Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Contract Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Contract Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Contract Packaging Market

A detailed market share analysis in the Pharmaceutical Contract Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Contract Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Contract Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Contract Packaging Market

A strategic analysis of the Pharmaceutical Contract Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Packaging Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almac Group, AmeriPac, Inc., Aphena Pharma Solutions Inc., Assemblies Unlimited Inc., Baxter Pharmaceutical Solutions LLC, Catalent, Inc., Central Pharma Contract Packing Limited, Daito Pharmaceutical Co., Ltd., Daklapack Group, Finishing Services, Jam Jams Group, Jones Healthcare Group, MJS Packaging, Nelipak Corporation, Nipro Corporation, Patheon Pharma Services by Thermo Fisher Scientific Inc., PCI Pharma Services, Pfizer Inc., Reed-Lane, Inc., Ropack Inc., Sepha Limited, Sharp Services, LLC, Southwest Packaging, SternMaid GmbH, Unicep Packaging, LLC, Wasdell Group, and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Material, market is studied across Aluminum Foil, Glass, Paper & Paperboard, and Plastics & Polymers.
• Based on Application, market is studied across Ampoules, Blister Packs, Bottles, and Vials.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need for convenient and tamper-free packaging in pharmaceutical industries
    • 5.1.1.2. Rise manufacturing and export of pharmaceutical products worldwide
    • 5.1.1.3. Stringent government standards for pharmaceutical packaging
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of advanced and customized pharmaceutical contract packaging services
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in pharmaceutical packaging solutions
    • 5.1.3.2. Significant investments in drug discovery and development
  • 5.1.4. Challenges
    • 5.1.4.1. Newly developed drugs conflicting with packaging material and advertising forged products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Contract Packaging Market, by Material

• 6.1. Introduction
• 6.2. Aluminum Foil
• 6.3. Glass
• 6.4. Paper & Paperboard
• 6.5. Plastics & Polymers

7. Pharmaceutical Contract Packaging Market, by Application

• 7.1. Introduction
• 7.2. Ampoules
• 7.3. Blister Packs
• 7.4. Bottles
• 7.5. Vials

8. Americas Pharmaceutical Contract Packaging Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Packaging Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Packaging Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Almac Group
• 3. AmeriPac, Inc.
• 4. Aphena Pharma Solutions Inc.
• 5. Assemblies Unlimited Inc.
• 6. Baxter Pharmaceutical Solutions LLC
• 7. Catalent, Inc.
• 8. Central Pharma Contract Packing Limited
• 9. Daito Pharmaceutical Co., Ltd.
• 10. Daklapack Group
• 11. Finishing Services
• 12. Jam Jams Group
• 13. Jones Healthcare Group
• 14. MJS Packaging
• 15. Nelipak Corporation
• 16. Nipro Corporation
• 17. Patheon Pharma Services by Thermo Fisher Scientific Inc.
• 18. PCI Pharma Services
• 19. Pfizer Inc.
• 20. Reed-Lane, Inc.
• 21. Ropack Inc.
• 22. Sepha Limited
• 23. Sharp Services, LLC
• 24. Southwest Packaging
• 25. SternMaid GmbH
• 26. Unicep Packaging, LLC
• 27. Wasdell Group
• 28. West Pharmaceutical Services, Inc.